Pradžia › Antsvoris › Minesota
Antsvoris klinikiniai tyrimai Minesota
13 tyrimai dėl Antsvoris ieško dalyvių vietose Minesota.
Miestai Minesota
Oficialus tyrimo tekstas (anglų kalba)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
Renkami dalyviai3 fazė
Amžius nuo 8 iki 18 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07253285A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07823608A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Headlands Research-Twin Cities, Maplewood
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07794579A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
Renkami dalyviai3 fazė
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
Renkami dalyviai3 fazė
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-22 · NCT06390345Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.